Douglas Joerss

Statistics

Publications

Citations

H-Index

Active since

2021

Affiliations

Infectious Disease Research Institute(Current)

Eli Lilly (United States)

Cornell University

Colorado State University

Douglas Joerss is an author at Infectious Disease Research Institute specializing in mycobacterium tuberculosis infection, drug discovery, and pharmacology.

Publications per year

2021–2022

Publications

Spirocycle MmpL3 Inhibitors with Improved hERG and Cytotoxicity Profiles as Inhibitors of <i>Mycobacterium tuberculosis</i> Growth

Peter C. Ray, Margaret Huggett, Penelope A. Turner et al. · ACS Omega · 2021 · 33 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +13

Spiropyrimidinetriones: a Class of DNA Gyrase Inhibitors with Activity against Mycobacterium tuberculosis and without Cross-Resistance to Fluoroquinolones

Gregory S. Basarab, Sandeep R. Ghorpade, Liezl Gibhard et al. · Antimicrobial Agents and Chemotherapy · 2022 · 26 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +16

Identification of β-Lactams Active against <i>Mycobacterium tuberculosis</i> by a Consortium of Pharmaceutical Companies and Academic Institutions

Ben Gold, Jun Zhang, Landys Lopez Quezada et al. · ACS Infectious Diseases · 2022 · 25 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +14

1–3 of 3